Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43146 (
tumour suppressor
)
5,935
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PIG11
(p53-induced gene 11) is a p53 target gene and candidate
tumour suppressor
gene. In this study, the expression of
PIG11
protein was detected in human hepatocellular carcinoma (HCC) and normal liver tissues with an immunohistochemical method. Compared with expression in human normal liver tissues, the expression of
PIG11
protein was significantly down-regulated in human HCC tissues. In addition, a recombinant pLXSN-
PIG11
retroviral vector was constructed and transfected into HepG2 cells (human hepatocellular carcinoma cell line) and the role of
PIG11
in apoptosis was analyzed. The percentage (18.60%) of apoptotic cells transfected with pLXSN-
PIG11
was higher than that in cells transfected with pLXSN only (6.03%) or the vehicle control (3.81%) (P < 0.01). DNA gel electrophoresis showed a clear DNA ladder in pLXSN-
PIG11
-infected HepG2 cells. Our results suggested that the
PIG11
gene is involved in carcinogenesis and development of hepatocarcinoma. Therefore,
PIG11
is considered to be a new candidate liver
tumour suppressor
gene, and may play an important role in tumour suppression through promotion of cell apoptosis.
...
PMID:PIG11 is involved in hepatocellular carcinogenesis and its over-expression promotes Hepg2 cell apoptosis. 1909 15